Loading...
XNYS
MRK
Market cap253bUSD
Dec 04, Last price  
100.89USD
1D
-1.35%
1Q
19.10%
Jan 2017
71.38%
Name

Merck & Co Inc

Chart & Performance

D1W1MN
XNYS:MRK chart
P/E
14.81
P/S
3.95
EPS
6.81
Div Yield, %
2.29%
Shrs. gr., 5y
-0.30%
Rev. gr., 5y
6.50%
Revenues
64.17b
+6.74%
22,011,900,00022,636,000,00024,197,700,00023,850,300,00027,428,300,00045,987,000,00048,047,000,00047,267,000,00044,033,000,00042,237,000,00039,498,000,00039,807,000,00040,122,000,00042,294,000,00046,840,000,00041,518,000,00048,704,000,00059,283,000,00060,115,000,00064,168,000,000
Net income
17.12b
+4,589.59%
4,631,300,0004,433,800,0003,275,400,0007,808,400,00012,901,300,000861,000,0006,272,000,0006,661,000,0004,404,000,00011,920,000,0004,442,000,0005,691,000,0002,568,000,0006,220,000,0009,843,000,0007,067,000,00013,049,000,00014,519,000,000365,000,00017,117,000,000
CFO
21.47b
+65.06%
7,608,500,0006,765,200,0006,999,200,0006,571,700,0003,392,000,00010,822,000,00012,383,000,00010,022,000,00011,654,000,0007,860,000,00012,421,000,00010,376,000,0006,447,000,00010,922,000,00013,440,000,00010,253,000,00014,109,000,00019,095,000,00013,006,000,00021,468,000,000
Dividend
Sep 16, 20240.77 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
URL
https://www.merck.com/
IPO date
Jan 01, 1941
Employees
67,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT